Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds
- PMID: 7954448
Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds
Abstract
BRCA1, a breast-ovarian cancer susceptibility gene which has been localized to 17q21, appears to be a tumor suppressor gene based on evidence from loss of heterozygosity (LOH) studies. We analyzed 14 ovarian and breast tumors from BRCA1 carriers and 1 sporadic breast tumor from 3 kindreds for 17q21 LOH. Thirteen of the 14 tumors from gene carriers exhibited LOH of the wild-type allele. Tumors from one gene carrier and the sporadic breast case did not exhibit any LOH in the region. There was loss of the wild-type allele from both maternally and paternally derived chromosomes, therefore excluding the possibility of genomic imprinting and providing further evidence that BRCA1 is a tumor suppressor. Three tumors showed interstitial LOH in the region, and thus established the utility of familial tumors in refining a region surrounding a tumor suppressor gene in a manner analogous to using genetic recombinants.
Similar articles
-
A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.Oncogene. 1996 Feb 15;12(4):735-40. Oncogene. 1996. PMID: 8632895
-
Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.Clin Cancer Res. 1995 May;1(5):539-44. Clin Cancer Res. 1995. PMID: 9816013
-
Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer.Cancer Res. 1996 Aug 15;56(16):3622-5. Cancer Res. 1996. PMID: 8705994
-
Mutations of the BRCA1 gene in human cancer.Semin Cancer Biol. 1996 Feb;7(1):33-40. doi: 10.1006/scbi.1996.0005. Semin Cancer Biol. 1996. PMID: 8695765 Review.
-
THe genetics of familial breast cancer.Semin Oncol. 1996 Feb;23(1 Suppl 2):1-5. Semin Oncol. 1996. PMID: 8614840 Review.
Cited by
-
Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance.Cancer Res. 2008 Apr 15;68(8):2581-6. doi: 10.1158/0008-5472.CAN-08-0088. Cancer Res. 2008. PMID: 18413725 Free PMC article.
-
BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality.Genes Dev. 2025 Jan 7;39(1-2):86-108. doi: 10.1101/gad.352083.124. Genes Dev. 2025. PMID: 39510841 Free PMC article. Review.
-
BRCA1 haploinsufficiency leads to altered expression of genes involved in cellular proliferation and development.PLoS One. 2014 Jun 20;9(6):e100068. doi: 10.1371/journal.pone.0100068. eCollection 2014. PLoS One. 2014. PMID: 24950059 Free PMC article.
-
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers.Nature. 2008 Feb 28;451(7182):1116-20. doi: 10.1038/nature06633. Epub 2008 Feb 10. Nature. 2008. PMID: 18264087 Free PMC article.
-
Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage.Cancer Sci. 2004 Nov;95(11):866-71. doi: 10.1111/j.1349-7006.2004.tb02195.x. Cancer Sci. 2004. PMID: 15546503 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous